|
|
||||||||
LETTER TO THE EDITOR |
Division of Cardiac Surgery, University of Verona, Piazzale Stefani 1, 37126 Verona, Italy
To the Editor:
We read with interest the paper by Benjacholamas et al. relative to the use of bicuspidized pulmonary homograft for right ventriculr outflow tract (RVOT) reconstruction in truncus arteriosus repair (1).
In their manuscript the Authors report on 15 patients (range, 28 days to 21 months) successfully operated upon for primary correction of truncus arteriosus associated with RVOT reconstruction by means of a bicuspidized valved conduit obtained by a conventional homograft (pulmonary = 14, aortic = 1) after one cusp resection. For the bicuspidized pulmonary homograft cohort, the reported in-hospital mortality was 20% (3/15), with a 5-year survival and a 5-year freedom from reoperation of 100%, respectively.
Benjacholamas and co-workers should be congratulated for their excellent results. The reported technique however, was not first introduced by Michler and colleagues (2), as mentioned in the manuscript, but by our group. Indeed, in 1993 in the July issue of the Journal of Cardiac Surgery we first reported on how to reduce the diameter of oversized homografts, in our series harvested from the heart of transplant recipients, making them suitable for correction of complex congenital heart disease in small children (3). At the beginning of our experience, extensively reported in several instances in the middle nineties literature (4–6) and counting now overall more than 20 implants, the bicuspid homografts were used for repair of tetralogy of Fallot with pulmonary atresia in 2 patients and for reconstruction of the left ventricular outflow tract in a patient with anatomically corrected transposition of the great arteries and pulmonary stenosis, with no mortality and excellent mid-term results.
Considering the demonstrated superiority of allograft over synthetic prostheses in the pediatric population and the ineluctability of subsequent replacement of conduits inserted in neonates or infants in the span of few years, indeed the reported technique represents a therapeutic option providing a conduit with excellent mid-term functional results when an appropriate-sized allograft is unavailable.
We understand that the motivating factors to choose this option may be shared by different surgical teams, but we also believe our group should be given the credit for its formal introduction.
REFERENCES
Asian Cardiovasc Thorac Ann 2009;
17:112
© 2009 by SAGE Publications
DOI: 10.1177/0218492309102642
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |